Wearables Funding Surges, Brain Tech Raises $250M, GRAIL Nears FDA Decision
September 25, 2026: Your daily rundown of health and wellness news, in under 5 minutes.
Today's top stories:
GRAIL's Galleri cancer blood test moves closer to FDA approval after an advisory panel found benefits outweigh risks, despite a near-split vote on efficacy
Wearables draw $4.1B in investment this year, nearing the 2021 peak as Whoop raises $575M and Oura preps a potential $16B public listing
Precision Neuroscience closes a $250M Series D, bringing total funding to $430M as its FDA-cleared brain-computer interface moves toward commercial use
Today's episode is brought to you by AIIR — a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.